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ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2005.05.052Background: Thoracotomy is associated with significant pain and morbidity.
Methods: We performed a prospective randomized trial over 4 months. Patients
were randomized to a standard posterior-lateral thoracotomy or an identical proce-
dure, except an intercostal muscle was harvested from the lower rib (to protect the
intercostal nerve) before chest retraction. To ensure an equal distribution among
both groups, patients were stratified by race, sex, and type of pulmonary resection.
All patients received similar pain management. Pain was assessed by using multiple
pain scores during hospitalization and after discharge. Outcomes assessed were pain
scores, spirometric values, analgesic use, and activity level.
Results: There were 114 patients. The median time for intercostal muscle harvesting
was 3.7 minutes. The numeric pain scores were lower for the intercostal muscle
group on postoperative days 1 and 2 and at weeks 1, 2, 3, 4, 8, and 12 (P  .05 for
all). In addition, patients in the intercostal muscle group had a smaller decrease in
spirometric values, were less likely to be using analgesics, and were more likely to
have returned to normal activity.
Conclusions: The harvesting of an intercostal muscle flap before chest retraction
decreases the pain of thoracotomy and leads to a lower decrease in spirometry. In
addition, patients have less pain at 1, 2, 3, 4, 8, and 12 weeks postoperatively and
are less likely to be using narcotics. Finally, it offers a pedicled muscle flap that
takes little time to harvest and is able to buttress all bronchi after lobectomy.
Lung cancer takes the life of approximately 170,000 Americans a year. It isresponsible for more deaths than the next 3 most common solid-organcancers combined. Worldwide, it is the leading cause of cancer deaths.1
Eighty percent of patients with lung cancer have non–small cell lung cancer, which
is potentially curable with surgical intervention if detected early and if completely
resected. Those with stage I, II, and even IIIa disease can be cured with pulmonary
resection, which is almost exclusively performed through a posterior lateral thora-
cotomy.1 However, thoracotomy is associated with significant pain and morbidity.
Studies have shown that chronic pain (pain after 6 months) is common and can
occur in up to 67% of patients.2-5 For these reasons, some have tried multiple
surgical incisions and approaches, as well as minimally invasive techniques, such as
video-assisted thoracoscopy (VATS). However, with VATS, one loses the ability to
feel the lung, it is difficult to remove all the thoracic lymph nodes, and very few
surgeons perform VATS lobectomy.
The main source of pain after thoracotomy is probably from injury to the
intercostal nerve.6,7 Over the past 4 years, we have studied the problem of pain after
thoracotomy by using prospective trials.8,9 In 2003, we found, in a prospective
study, that sutures placed through the ribs (intracostal sutures) decreased the pain
when compared with sutures that go around the ribs (paracostal sutures) during
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nerve. Thus we evaluated whether we could further reduce
pain by avoiding injury to the intercostal nerve during
opening. We theorized that if one could take down (or
harvest) part of the intercostal muscle (ICM) that lies in
between the ribs and prevent it from being crushed by the
upper blade of the chest retractor, the pain of a thoracotomy
might be even further lessened. Thus we conducted a pro-
spective randomized trial comparing the pain of these pa-
tients with the pain of those who underwent a standard
thoracotomy (Figure 1).
Material and Methods
Entry Criteria
Between February 1, 2004, and July 30, 2004, all asymptomatic
patients who were to undergo a posterior lateral thoracotomy for
an indeterminate pulmonary nodule or for biopsy-proved non–
small cell lung cancer performed by one general thoracic surgeon
(RJC) at the University of Alabama in Birmingham were eligible
for this trial. Patients were excluded if they were younger than 19
years; presented with any type of pain; had a history of chronic
pain syndrome, methadone use, psychiatric illness, or previous use
of opiates or steroids 6 month before the operation; had a previous
thoracotomy; received neoadjuvant therapy; or refused entry into
the trial. If sleeve lobectomy or pneumonectomy was anticipated,
patients were excluded because an ICM flap was used to cover the
bronchi. Patients who presented with chest pain or asymptomatic
patients with radiologic evidence of parietal pleural or rib invasion
were also excluded. Careful preoperative assessment, including
pulmonary function tests, cardiac stress tests, echocardiography,
computed tomography, and positron emission tomography, were
Figure 1. Intracosperformed in all patients.
988 The Journal of Thoracic and Cardiovascular Surgery ● OctoIn addition, patients had spirometry performed during their
preoperative clinic visit. This was performed by asking the patient
to take 2 deep breaths and then blow out as hard as possible into
the incentive spirometer 3 times. The spirometric value for each
breath was recorded and averaged. The same technique was used
each day in the hospital.
Patients meeting the enrollment criteria were randomly as-
signed the day of the operation to either the ICM group or the
standard group. They were stratified by race, sex, and resection
type to ensure an equal distribution of patients in the 2 groups.
Only the surgeon and his surgical team were aware of the patient
assignment. Office staff, who were responsible for surveying pa-
tients, performing data entry, and performing telephone surveys, as
well as the patients themselves, were blinded to the patient ran-
domization assignment.
Intraoperative Technique
All patients had an epidural placed preoperatively before the
operation. If the epidural was deemed to be nonfunctional at any
time postoperatively by the pain service, the patient was eliminated
from the study. If patients had significant complications (ie, con-
fusion, transfer to the intensive care unit, or requirement for
intubation) that precluded them from participating in the study,
they were also eliminated. If patients had prolonged air leaks and
were sent home with a chest tube in place on a Heimlich valve,
they were also excluded. All openings and closings were per-
formed by one surgeon, with various cardiothoracic fellows and
general surgical residents. All patients had skin incisions the length
of the posterior half of their latissimus dorsi muscle. The posterior
half of the latissimus dorsi was cut, and the entire serratus anterior
muscle was preserved. Once the sixth rib was identified, the ICM
above it, as well as 2 ICM bundles above and 2 below, were all
uscle (ICM) flap.tal minjected with bupivacaine (Marcaine; Abbott Labs, North Chicago,
ber 2005
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calculated, and 50% of this dose was drawn into a syringe. It was
then injected evenly into the 5 ICMs with an 18-gauge needle. The
chest was entered over the top of the sixth rib in all patients. The
rib was not cut or shingled. At this point, the surgeon was made
aware of into which group the patient was randomized. Those
patients randomized to the standard group had the chest retractor
placed with one blade against the sixth rib and the other against the
fifth ICM that was still attached to the lower aspect of the fifth rib.
Those patients randomized into the ICM group had the fifth ICM
harvested off of the inferior edge of the fifth rib by use of a cautery.
The muscle was deflected downward with a forceps during the
harvesting, which allows the flap to remain viable so it can be used
later to cover or buttress the bronchi after lobectomy. The ICM
was taken down off most of the rib. It was cut just under the
serratus anterior muscle, and posteriorly it was kept intact because
the blood supply comes from this area. During the pulmonary
resection, the muscle was retracted out of the way. We attempted
to avoid rib fracture by slowly opening the chest retractor.
After completion of the appropriate pulmonary resection and
thoracic lymphadenectomy, patients had one or two 28F soft chest
tubes placed. Patients who underwent lobectomy had 2 tubes
placed; patients who had a segmentectomy and wedge resection
received only 1 tube. All patients had intracostal sutures used for
closure. Patients then received identical postoperative pain regi-
mens. Epidurals were removed on the morning of postoperative
day (POD) 2 in all patients, and oxycodone and acetametaphin
(Tylox; McNeil Pharmaceuticals, Springhouse, Pa) were used as
well. Ketorolac tromethamine (INN: ketorolac; Toradol, Nutley,
NJ) was administered to all patients in the recovery room and daily
until POD 2 as well. Intravenous morphine was used for break-
through pain. Members of the pain service who managed the
epidural and the nurses on our team, nurses on the floor, and data
collectors were all blinded to patient randomization assignment.
Pain Score Assessment
Postoperatively, pain scores were objectively measured and re-
corded. The numeric rating scale,10 visual pain score,11 and verbal
descriptor scale12 were used for patients while hospitalized.
Each patient was interviewed each day between 3 PM and 7 PM
by a blinded study coordinator. Interviews were conducted by
using the same script each day. Patients usually received oral
analgesics between 2 PM and 6 PM. The amount of pain medicines
used was also recorded. In-hospital complications were noted, and
daily chest roentgenograms were performed.
Once discharged, the visual pain assessment score was not
used; however, the numeric and descriptive scales were used. One
of 2 interviewers called patients at home and assessed their pain
using a standard outpatient script. The calls were made between 1
PM and 5 PM at postoperative weeks 1, 2, 4, 8, and 12. If patients
returned for a 3-week postoperative check in the clinic, a numeric
pain score was recorded by using the same script as in the hospital.
The amount of pain medicines used was also recorded. The Insti-
tutional Review Board of the University of Alabama in Birming-
ham approved this study, along with the prospective database used
concomitantly.
The Journal of ThoraciStatistical Analysis
A power analysis performed before commencing this study indi-
cated that a total of 150 patients (75 patients in each group) were
needed. An interim analysis was planned to be performed after
approximately 50 patients were enrolled in each group. Data for all
patients who were randomly assigned to a group were analyzed on
an intention-to-treat basis. Given the need to randomize patients
before the operation in this study, patients who had significant
operative morbidity were excluded from the study and any anal-
ysis. Patient characteristics are provided in Table 1.
For the analysis of differences between groups, we used
2-tailed t tests, or if the results were not normally distributed, we
used nonparametric tests. Fisher exact or 2 tests were used to
compare proportions. An analysis of variance for repeated mea-
surements was performed to compare the pain scores for the 2
TABLE 1. Patient and pathologic characteristics*
ICM group Standard group
No. of patients 56 58
Mean age (y) 66 65
Sex
Male 29 (52%) 30 (52%)
Female 27 (48%) 28 (48%)
Race
White 49 (88%) 50 (86%)
Black 7 (12%) 8 (14%)
BMI (mean) 30.5 29
Pulmonary function test
FEV1 (%) 81 72
MVV (%) 62 64
DLCO (%) 84 76
Types of procedure
Segmentectomy 6 (11%) 7 (12%)
Lobectomy 37 (66%) 38 (66%)
Wedge 13 (23%) 13 (22%)
Stage
Benign 10 (18%) 14 (24%)
Ia, Ib 12 (21%) 12 (21%)
IIa, IIb 20 (36%) 19 (33%)
IIIa, IIIb 3 (5%) 2 (4%)
IV 3 (6%) 4 (7%)
Metastatic disease 8 (14%) 7 (2%)
Histology
Benign, infectious, or
inflammatory
cause
12 (22%) 15 (26%)
Adenocarcinoma 17 (30%) 18 (30%)
Squamous cell
carcinoma
14 (25%) 14 (24%)
Other NSCLC 5 (9%) 5 (9%)
Metastatic nodule 8 (14%) 7 (12%)
ICM, Intercostal muscle; BMI, body mass index; FEV1, forced expiratory
volume in 1 second; MVV, maximal voluntary ventilation; DLCO, diffusion
capacity of the lung for carbon monoxide; NSCLC, non–small cell lung
cancer. *P  .05 for all variables.groups. Time to the resumption of normal activity (ie, percentages
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General Thoracic Surgery Cerfolio et al
G
TSfor categoric variables) was analyzed with Kaplan-Meier survival
curves, and differences between the 2 treatment groups were
compared by using the log-rank test.
Results
One hundred eighty-one patients underwent elective pulmo-
nary resection during this time frame, and 145 (77%) met
the entry criteria, agreed to enroll in the study, and were
randomized. Of those randomized, 114 (78%) patients re-
mained in the study. Table 1 shows the randomization was
successful because there were no statistically significant
TABLE 2. Reasons for exclusions from trial after
randomization
Reason for exclusion
ICM
group
Standard
group Total
Loss to follow-up 2 3 5
Epidural nonfunctional or
accidentally dislodged
3 2 5
Patients transferred to ICU
for cardiac shock, stroke,
ARDS
2 3 5
Sent home with chest tube in
on Heimlich valve
4 8 12
Marcaine not injected into
ribs before rib spreading
0 1 1
Tumor growing into parietal
pleural surface of
intercostal muscle
1 0 1
Refused to answer
postoperative pain survey
0 1 1
Required chest wall resection 0 1 1
Total 12 19 31
ICM, Intercostal muscle; ICU, intensive care unit; ARDS, adult respiratory
distress syndrome.
TABLE 3. Pain assessment for the 2 groups during the hos
ICM group
Standard
group ICM g
Postoperative day 1 1 2
No. of patients 56 58 55
Numeric rating scale(of 10) 2.29(P  .04) 4.50 2.91(P
Visual (of 6) 1.60(P  .03) 2.27 2.2
Descriptor, patients w/mild
to no pain
86%(48) 71%(41) 95%
Decrease in spirometry 53% 44% 28%(P
Patients ambulatory 100% 98% 100
Patients epidural 100% 100% 5.4%
Patients with chest tube(s)
in place
100%(56) 100%(58) 69%
Patients using PO pain
medications (%)
0% 5%(3) 94%Means are reported, and statistically significant P values that favor one group
990 The Journal of Thoracic and Cardiovascular Surgery ● Octodifferences between patients in the ICM and standard
groups for previously identified variables for pain. Table 2
shows the reasons for the elimination of 31 patients after
randomization.
Intraoperative Outcomes
Patients randomized to the ICM group had a higher inci-
dence of a broken rib compared with those randomized to
the standard group (19 [34%] vs 8 (13%), respectively; P 
.025). The mean time to perform an ICM procedure was 3.7
minutes. The mean number of chest tubes placed was the
same for both groups (2). The mean days of hospital length
of stay (4.32 vs. 4.39 days, respectively) and number of
patients who received adjuvant chemotherapy (7 vs 5, re-
spectively) for the ICM and standard groups were relatively
similar.
In-hospital Outcomes
Table 3 depicts the pain scores in the hospital for each POD.
It shows patients in the ICM group had a significantly lower
numeric pain score on PODs 1 and 2, a lower visual pain
score on PODs 1 (2.29 vs 4.5) and 2 (2.91 vs 4.38, P .04),
and also a lower visual pain score on POD 1 for the patients
in the ICM group compared with those in the standard group
(1.6 vs 2.27, P .04). There were no statistically significant
differences seen in the outcomes of the descriptor pain
score. Almost all patients in both groups were ambulatory
starting on POD 1. Patients in the ICM group had less of a
decrease in their spirometry values on all PODs, with a
statistically significant difference on PODs 2 and 3. There
was no difference between the 2 groups for the amount of
pain medicine used while in the hospital. Hospital compli-
cations are shown in Table 4. Only 1 patient in the ICM
group had pulmonary complications (other than prolonged
lization
Standard
group ICM group
Standard
group ICM group
Standard
group
2 3 3 4 4
54 51 52 42 43
) 4.38 2.54 2.81 2.37 2.56
2.48 1.79 1.86 1.51 1.76
93%(50) 86%(44) 92%(48) 97%(41) 95%(41)
) 36% 11%(P  .02) 23% 16% 35%
100% 100% 100% 100% 100%
3.8%(2) 0% 0% 0% 0%
69%(37) 27%(14) 31%(16) 5.2%(8) 7.3%(7)
96.4%(54) 100% 100% 100% 100%pita
roup
 .04
4
(52)
 .03
%
(3)
(38)
(50)appear under that group’s score. ICM, Intercostal muscle; PO, by mouth.
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the standard group.
Long-Term/Outpatient Outcomes
An analysis of variance showed that the patients in the ICM
group had lower numeric pain scores than the patients in the
standard group (P  .004). Table 5 shows the numeric pain
scores at each week postoperatively. A pain score was also
TABLE 4. Patient complications while in the hospital
ICM group Standard group
No. of patients 56 58
Pulmonary
Pneumonia 1 3
Reintubated 0 1
GI
Ileus 1 1
Diverticulitis 1 0
Cardiovascular
Atrial arrhythmia* 4 13
Urinary
Urinary retention 1 0
Total* 8 18
ICM, Intercostal muscle; GI, gastrointestinal. *Significantly different (P 
.05).
TABLE 5. Postoperative assessment
ICM group
Standard
group
ICM
group
Standard
group
IC
gro
Postoperative wk 1 1 2 2 3
No. surveyed 56 57 54 53 3
Numeric rating
score
2.63† 4.0 2.13† 3.44 0.5
Verbal descriptor
scale, patients
who reported
mild or no
discomfort
91%(51),
P  .03
79%(42) 88%(48) 79%(42) N
Patients
readmitted
within 30 d of
the operation
2%(1) 2%(1) 5.6%(3) 4%(2) N
Patients using
pain medicine
95%(53) 95%(54) 81%(44) 91%(48) N
Patients
receiving
adjuvant
treatment
0 0 0 0 0
Patients satisfied
with procedure
and care
95%(53) 96%(55) 96%(52) 98%(52) 100
ICM, Intercostal muscle; NA, not applicable. *Pain score assessed in perso
week postoperatively. †P  .05.
The Journal of Thoraciobtained during the patients’ 3-week postoperative clinic
visits. The difference between the 2 groups achieved statis-
tical significance at all weeks measured (1, 2, 3, 4, 8, and
12). Those in the ICM groups were less likely to use
analgesics at 2, 4, 8, and 12 weeks postoperatively, and this
difference was statistically significant at weeks 4 and 8. In
addition, patients in the ICM group were more likely to
return to their normal daily activities sooner than those
patients randomized to the standard group (3 weeks com-
pared with 8 weeks, respectively; P  .0219).
Discussion
Pain is inherently difficult to study because by its nature it is
subjective. For these reasons, over the past several years, we
have performed studies designed to limit as many confounding
variables as possible. We have used only one surgeon who,
despite the presence of surgical assistants, residents, and fel-
lows, opens and closes all patients. We have used identical
selection criteria, intraoperative techniques, and postoperative
management and changed only one small variable at a time.
We have applied the best available scores, scales, and mea-
surements of pain to objectify pain and to quantify it as best as
possible. And we have used only prospective trials, prospective
randomized trials, or both. Yet no study that assesses a pa-
tient’s pain is perfect.
Standard
group
ICM
group
Standard
group
ICM
group
Standard
group
ICM
group
Standard
group
3* 4 4 8 8 12 12
36 48 45 44 42 40 38
2.40 1.5† 2.8 1.32† 2.53 1.2† 2.68
NA 92%(44) 84%(38) 88%(39) 88%(37) 78% 72%
NA 10.4%(5) 6.7%(3) NA NA NA NA
NA 35%†(17) 62%(28) 16%†(7) 41%(18) 8%(3) 13%(5)
0 4 3 7 6 9 8
100% 92%(44) 100%(45)89%(39) 88%(37) 88%(35) 84%(32)
ime of postoperative clinic visit, which was normally done during the thirdM
up
*
5
1†
A
A
A
%
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the avoidance of retraction on the ICM and the nerve that
runs in it significantly reduces pain. In fact, this study was
stopped early because of the statistically significant differ-
ences between the 2 groups. The strengths of this study are
its strict methodology, including rigid inclusion-exclusion
criteria, set times, and standardized scripts for patient pain
surveys; the use of 3 different pain scales; and the evalua-
tion of objective data, such as the spirometric measurements
and pain medication use. The limitations of our study lie
within the subjective nature of pain itself.
Surprisingly, we also found that those patients in the
ICM group had less pain during the first and second days of
hospitalization, despite the fact that all patients had func-
tioning epidurals and other analgesics available to them.
Perhaps most important is that this decrease in pain might
allow patients to breathe deeper, and this could reduce some
respiratory complications, such as pneumonia and mucous
plugging, which remain significant vexing problem after
thoracotomy and pulmonary resection. The pathophysio-
logic mechanism for this result can be seen in another
finding in this study: spirometry. Patients in the ICM group
had less of a reduction of their spirometric values than those
in the standard group. Perhaps an ICM flap further reduces
postoperative pain and allows patients to breath deeper and
better aerate the lung. Further studies are needed to corrob-
orate this finding and the precise physiology.
An ICM flap is easy to perform, does not require any
special equipment, and takes little time. However, occasion-
ally, a cancer invades that part of the chest wall or the parietal
pleural that runs under the ICM. In this situation it must be
resected en block with the cancer. We also found that when the
ICM was harvested, we were more likely to break the lower
rib. This might be because the upper rib is less protected after
the muscle has been removed from much of its surface. Inter-
estingly, however, we did not find that having a broken rib was
associated with more pain. This might be because we ensured
that when we closed the chest, the ends of the broken ribs were
well secured together and not rubbing.
The ideal way to perform a thoracotomy to minimize
pain is not known. However, the best treatment of pain
might be prevention. This is based on the peripheral and
central hypersensitivity that occurs after tissue or nerve
injury.13,14 A study by Katz and colleagues5 demonstrated
that patients with long-term pain were more likely to have
had significantly greater pain intensity 24 hours after sur-
gical intervention. Therefore modification of surgical tech-
niques that can decrease acute pain might also decrease
chronic pain. Some surgeons prefer a vertical axially tho-
racotomy,15 and others prefer a muscle-sparing thoracoto-
my.7,16 Previous prospective randomized trials showed no
benefit for a muscle-sparing thoracotomy when compared
with a non–muscle-sparing technique.17 We performed a
992 The Journal of Thoracic and Cardiovascular Surgery ● Octoprospective trail in 2003 and found that avoiding the nerve
at closure can significantly decrease pain. It also changed
the patient’s perception of that pain and made it less likely
to be described as “searing” or “burning.”
The concept of harvesting an ICM flap is probably not
new. Since performing this study, we have become aware
that some surgeons have used it. However, its advantages
have never been critically studied. When we used both the
ICM flap and the intercostal sutures, we eliminated the
problem of chronic pain (pain after 6 moths) in all patients
thus far. The vast majority of patients are therefore able to
undergo posterior-lateral thoracotomy, pulmonary resec-
tion, and complete thoracic lymphadenectomy and have a
pain score of only 1, 2, or 3 at 3 to 4 weeks postoperatively.
Most are off of all narcotics, are back at work, and are able
to resume all physical activities without restriction. Those in
the ICM group were more likely to have returned to their
baseline activities by 1 month compared with those in the
standard group.
On the basis of these findings, we recommend the use of
an ICM flap as a way to decrease the pain of thoracotomy.
In addition, it affords a versatile and vascularized muscle
that is extremely useful. It can be used to buttress all bronchi
after lobectomy or segmentectomy. It can also be used to
support or cover esophageal repair. Coverage of the bronchi
is recommended after pneumonectomy and for the patients
who are at risk of bronchopleural fistula.18 This includes
those who have had preoperative radiation or chemotherapy
and those who are immunocompromised. When harvested
as described in this study, an ICM flap is devoid of perios-
teum, and it does not calcify over time. Our future plans are
to study further reduction in pain by leaving the nerve intact
distally, without division of the ICM, and yet still avoid the
nerve from being crushed by the retractor.
In conclusion, the harvesting of an ICM flap is a simple
surgical modification to thoracotomy that can decrease acute
and chronic pain. This reduction in pain leads to less decrease
in spirometric values. This technique reduces pain after dis-
charge at 1, 2, 3, 4, 8, and 12 weeks postoperatively. Patients
were less likely to require analgesics and were more likely to
have returned to normal activities by 1 month.
We thank Cyndi Bass, RN, MSN, CRNP; Jeana Alexander,
RN; and Sandra Calloway and Steven Goldberg, MD, for their
assistance with this trial and with the care of these patients.
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